Insmed (INSM) Gross Margin (2018 - 2026)

Insmed (INSM) posted quarterly Gross Margin of 84.5% for Q1 2026, up 742.0% year-over-year from 10.04% in Q1 2025, and up 1.52% quarter-over-quarter from 83.24% in Q4 2025.

Insmed (INSM) Gross Margin (2018 - 2026) Analysis & Trends

Insmed's Gross Margin history runs 9 years deep, the most recent figure standing at 84.5% for Q1 2026.

  • In Q1 2026, Gross Margin rose 742.0% year-over-year to 84.5%; the TTM figure through Mar 2026 stood at 81.81% (up 532.0% YoY), while the FY2025 annual figure was 79.73%, up 330.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 84.5%, up from 83.24% in the prior quarter.
  • The five-year high for Gross Margin was 84.5% in Q1 2026, with the low at 73.86% in Q2 2025.
  • The 5-year median for Gross Margin is 77.96% (2022), against an average of 78.13%.
  • The sharpest annual moves came in 2024 and 2025: Gross Margin plunged 300 bps in 2024, then surged 828 bps in 2025.
  • Insmed's Gross Margin stood at 77.96% in 2022, then gained by 0 bps to 77.96% in 2023, then retreated by 4 bps to 74.96% in 2024, then rose by 11 bps to 83.24% in 2025, then rose by 2 bps to 84.5% in 2026.
  • Business Quant data shows INSM's Gross Margin at 84.5% in Q1 2026, 83.24% in Q4 2025, and 79.37% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 91.59%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 90.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 89.76%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 60,631,834.75%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 76.90%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 84.20%
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn 80.31%

Historic Data

Download Data
DateValue
Jun 30, 2026 84.20%
Mar 31, 2026 84.50%
Dec 31, 2025 83.24%
Sep 30, 2025 79.37%
Jun 30, 2025 73.86%
Mar 31, 2025 77.08%
Dec 31, 2024 74.96%
Sep 30, 2024 77.34%
Jun 30, 2024 76.79%
Mar 31, 2024 76.88%
Dec 31, 2023 77.96%
Sep 30, 2023 78.87%
Jun 30, 2023 78.51%
Mar 31, 2023 78.79%
Dec 31, 2022 77.96%
Sep 30, 2022 80.11%
Jun 30, 2022 74.86%
Mar 31, 2022 77.04%
Dec 31, 2021 76.32%
Sep 30, 2021 78.22%